12 However, the benefits of liraglutide in reducing weight, hepatic steatosis, and hepatocellular apoptosis in obese adults with MASLD were not sustained upon discontinuation, especially when compared to lifestyle modifications (NCT02654665)
Endocrinology, 151(4), 14731486
Generic biosimilar insulin glargine products have also begun to enter the market, potentially reducing costs for patients who need this medication class
Injectable therapies often include options such as Vitamin B12 or lipotropic injections to support energy, metabolism, and weight management
Treatment duration and review should follow NICE guidance for Wegovy (TA875), which specifies a maximum treatment duration of 2 years and continuation only if at least 5% weight loss is achieved at 6 months